Baxter Reports Q4 2024 Earnings Exceeding Guidance Despite Hurricane Impact
Baxter (BAX) reported Q4 2024 revenue of $2.75 billion, surpassing guidance and showing a 1% increase, though adjusted EPS fell 11% year-over-year due to Hurricane Helene. Full-year sales rose 3%, and the Medical Products & Therapies segment outperformed expectations.
Tickers: $BAX
Topics: Earnings Guidance Hurricane Impact Revenue Segment Performance